At a two-acre facility on the outskirts of Bengaluru, off Tumkur Road, 14 dogs are busy ticking off all their daily KRAs—swimming, walking, lolling, playing, eating. Well, almost all. These dogs’ duties include one very important task—sniffing out cancer.
As click-bait-y and preposterous as it sounds, that’s what they actually do at Dognosis, a health-tech startup that is putting the olfactory abilities of dogs to work in early cancer detection. It’s not the first time that canines have been enlisted to detect diseases. Dogs have been known to detect medical conditions, including cancer, for close to two decades. In fact, during the Covid-19 pandemic, several organisations across the world trained dogs to discern the onset of the respiratory illness. And that was the premise for Dognosis co-founders Akash Kulgod and Itamar Bitan.
“In June 2021, when India had a really bad Covid wave, my father, a doctor, was directing a Covid hospital. We weren’t able to diagnose symptoms before people spread it to others. At the same time, I learned that across the world, in 60 organisations, people were training dogs to detect Covid. And the dogs were better than RT-PCR tests. It was kind of mind-blowing to me that dogs could detect diseases and no one had really done anything about it,” says Kulgod, a cognitive science graduate from Berkley who was, at the time, back in his hometown in Belgaum on a gap semester.
Bitan (27) came at the problem from a different direction. An Israeli national with a background in professional canine training, he had worked with dogs in a special-operations bomb-detection unit before moving into disease detection. He had spent two years training dogs to identify conditions such as Parkinson’s and breast cancer, when the two crossed paths in 2023. While Kulgod understood the science of behaviour, cognition, and AI, Bitan knew how to train dogs. It was a good match.










